FDA approves groundbreaking new pancreatic cancer drug
The Food and Drug Administration (FDA) on Wednesday approved a treatment for advanced pancreatic cancer, offering new life-extending care for patients with one of the most aggressive forms of cancer.
The once-daily pill, called daraxonrasib and manufactured by Revolution Medicines, will be sold under the brand name Rasonque.
It was approved for patients who already tried...
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on thehill.com — the content belongs to The Hill.
